These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31301370)

  • 1. Clinical relevance of ethanol coingestion in patients with GHB/GBL intoxication.
    Galicia M; Dargan PI; Dines AM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; ; Wood DM; Miró Ò;
    Toxicol Lett; 2019 Oct; 314():37-42. PubMed ID: 31301370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.
    Miró Ò; Galicia M; Dargan P; Dines AM; Giraudon I; Heyerdahl F; Hovda KE; Yates C; Wood DM; Liakoni E; Liechti M; Jürgens G; Pedersen CB; O'Connor N; Markey G; Moughty A; Lee C; O'Donohoe P; Sein Anand J; Puiguriguer J; Homar C; Eyer F; Vallersnes OM; Persett PS; Chevillard L; Mégarbane B; Paasma R; Waring WS; Põld K; Rabe C; Kabata PM
    Toxicol Lett; 2017 Aug; 277():84-91. PubMed ID: 28579487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs.
    Heier EC; Eyer F; Rabe C; Geith S; Dargan PI; Wood DM; Heyerdahl F; Dines AM; Giraudon I; Erik Hovda K; Yates C; Vallersnes OM; Miró Ò; Liechti ME; Zellner T;
    Eur J Emerg Med; 2022 Aug; 29(4):291-300. PubMed ID: 35404314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
    Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
    QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of patients with analytically confirmed γ-hydroxybutyric acid/γ-butyrolactone (GHB/GBL)-related emergency department visits in Taiwan.
    Weng TI; Chen LY; Chen JY; Chen GY; Mou CW; Chao YL; Fang CC
    J Formos Med Assoc; 2021 Oct; 120(10):1914-1920. PubMed ID: 33893011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
    Liechti ME; Kunz I; Greminger P; Speich R; Kupferschmidt H
    Drug Alcohol Depend; 2006 Feb; 81(3):323-6. PubMed ID: 16143455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inpatient management of GHB/GBL withdrawal.
    Delic M
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):354-356. PubMed ID: 31488752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of withholding intubation in gamma-hydroxybutyrate- and gamma-butyrolactone-intoxicated coma patients in the emergency department.
    van Helmond LPFM; Gresnigt FMJ
    Eur J Emerg Med; 2020 Jun; 27(3):223-227. PubMed ID: 31815871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.
    Corkery JM; Loi B; Claridge H; Goodair C; Corazza O; Elliott S; Schifano F
    Neurosci Biobehav Rev; 2015 Jun; 53():52-78. PubMed ID: 25843781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.
    Liakoni E; Walther F; Nickel CH; Liechti ME
    Scand J Trauma Resusc Emerg Med; 2016 Aug; 24(1):107. PubMed ID: 27581664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal differences in γ-hydroxybutyrate overdoses involving injecting drug users versus recreational drug users in Helsinki: a retrospective study.
    Boyd JJ; Kuisma MJ; Randell TT
    Scand J Trauma Resusc Emerg Med; 2012 Feb; 20():7. PubMed ID: 22296777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intubation for gamma-hydroxybutyric acid overdose on emergency department length of stay and hospital admission.
    Dietze P; Horyniak D; Agius P; Munir V; Smit de V; Johnston J; Fry CL; Degenhardt L
    Acad Emerg Med; 2014 Nov; 21(11):1226-31. PubMed ID: 25377399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
    McDaniel CH; Miotto KA
    J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [GHB--dangerous, addictive and uncontrollable "party drug"].
    Persson SA; Eriksson A; Hallgren N; Eklund A; Berkowicz A; Druid H
    Lakartidningen; 2001 Sep; 98(38):4026-31, 4033-5. PubMed ID: 11602959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats.
    Baker LE; Van Tilburg TJ; Brandt AE; Poling A
    Psychopharmacology (Berl); 2005 Sep; 181(3):458-66. PubMed ID: 16001124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex.
    Busardò FP; Gottardi M; Tini A; Minutillo A; Sirignano A; Marinelli E; Zaami S
    Curr Drug Metab; 2018; 19(13):1080-1085. PubMed ID: 30251602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone.
    Lenz D; Rothschild MA; Kröner L
    Ther Drug Monit; 2008 Dec; 30(6):755-61. PubMed ID: 18824955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.
    Palmer RB
    Toxicol Rev; 2004; 23(1):21-31. PubMed ID: 15298490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.